CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Open-market sale Chief Medical Officer sold 26,570 shares at $3.59 ($95,511)
- 4 Exercise or conversion Director acquired 5,128 shares (option exercise)
- 4 Open-market buy Director bought 3,614 shares at $4.75 ($17,165)
- 4/A Open-market buy Director bought 0 shares
- 4 Open-market buy Director bought 1,000 shares at $4.15 ($4,150)
- 4 Open-market buy Director bought 3,614 shares at $4.15 ($14,998)
- 4 Open-market buy Director bought 9,639 shares at $4.15 ($40,002)
- 4 Open-market buy Director bought 2,410 shares at $4.15 ($10,002)
- 4 Open-market buy Director bought 24,096 shares at $4.15 ($99,998)
- 4 Open-market buy Director bought 20,000 shares at $4.15 ($83,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 15,000 shares at $4.19 ($62,850)
- 4 Exercise or conversion Chief Scientific Officer acquired 13,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 12,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 30,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,282 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 30,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
- 4 Open-market sale SVP Reg. & Quality sold 30,000 shares at $5.33 ($159,828)
- 4 Exercise or conversion Director acquired 4,297 shares (option exercise)
Page 13 of 36 · 701 filings